Pfizer’s Prevenar 13® receives approval for use in infants and children in China

Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its pneumococcal 13-valent conjugate vaccine, Prevenar 13®, in China for a…
Read the full story: Breaking World Pharma News